• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, July 29, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Grant funds opioid addiction treatment in two county jails

Bioengineer by Bioengineer
February 21, 2019
in Health
Reading Time: 3 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

UMass Amherst researcher helps oversee innovative program in Western Massachusetts

IMAGE

Credit: UMass Amherst


In what could serve as a model for tackling one of the nation’s top public health crises, a University of Massachusetts Amherst epidemiology researcher is teaming up with two Western Massachusetts sheriff’s offices to design, implement and study an opioid treatment program for jail detainees in Franklin and Hampshire counties.

Funded with a $1.5 million grant from the federal Subtance Abuse and Mental Health Services Administration, the three-year project aims to deliver medications to some 500 detainees who agree to treatment, and connect them to follow-up care through a comprehensive community reentry program after their release.

Elizabeth Evans, assistant professor in the School of Public Health and Health Sciences and one of the grant recipients, will collect data from all the stakeholders to measure the project’s outcomes. “The idea is to distill the lessons learned into a playbook or guide that can be used in jails in Massachusetts and across the nation,” Evans says.

The opioid crisis has grown so severe that Americans are now more likely to die from an unintentional opioid overdose than in a vehicle crash or any other accident, according to the National Safety Council.

Opioid addiction “is probably the issue of the 21st century in terms of public health,” Evans says, and the project reflects a shift in the approach to addressing the crisis. “Evidence supports the use of medications to treat opioid use disorder. This model signifies a willingness of the sheriffs to deliver care to reduce recidivism and to save people’s lives,” she says.

Evans will help Franklin County Sheriff Christopher Donelan, Assistant Superintendent Ed Hayes and their staff expand and formalize the groundbreaking opioid treatment they began offering inmates in 2015 at the county jail in Greenfield. She also will work with Hampshire County Sheriff Patrick Cahillane, Assistant Superintendent Melinda Cady and their staff to implement the same program in the Northampton jail.

The location of the rural counties along Interstate 91 leaves residents particularly exposed to the effects of opioid trafficking. For many of the jail detainees, it will be their first opportunity to receive evidence-based care for their disorder, Evans says. “This is a health condition,” she says. “And this is a very vulnerable population.”

Each of the jails has a medical director who assesses the need for treatment, prescribes the medication and monitors the detainees who receive it. An estimated 40 percent of inmates at both jails report having an opioid problem, Evans says, and most are willing to receive treatment, which can begin in as few as four days after arrest.

The treatment medications include Suboxone, which contains buprenorphine and naloxone to help ease cravings and the severe, flu-like symptoms associated with withdrawal; and Vivitrol, an opiate-blocker given as an injection that lasts about a month. Jail authorities also are seeking DEA approval to offer methadone, a synthetic opioid commonly used to treat opioid use disorder.

“People who experience withdrawal develop a fear of ever experiencing that again,” Evans says, which helps explain both the cycle of addiction and the high risk of overdose for detainees following their release from jail.

According to a 2018 Massachusetts Department of Public Health report, the opioid overdose death rate is 120 times higher for recently released inmates than for other adults. And the first month after release is a critical time.

“We recognize that the period after release from jail is a high-risk period for overdose and death from opioids,” Evans says. “The inmates’ tolerance changes and their bodies cannot withstand the same amount of substances as they could pre-incarceration. They often return to use at the same level, which becomes a lethal dose for them.”

That’s why connecting people to medication providers and social services after their release from jail is a crucial part of the program, Evans says.

Franklin and Hampshire counties are among seven in the Commonwealth in a pilot program mandated by the Massachusetts Legislature to start offering medication to inmates with opioid use disorder by September. Evans says the data gathered from the three-year project in Franklin and Hampshire counties may inform the Commonwealth’s burgeoning plan for jail-based opioid addiction treatment.

“Jails used to be all about public safety,” Evans says. “Now they are taking on a public health role. This has potential benefits to both the incarcerated people and to us as a society.”

###

Media Contact
Patty Shillington
[email protected]
305-606-9909

Original Source

https://www.umass.edu/newsoffice/article/grant-funds-opioid-addiction-treatment-two

Tags: AddictionDrugsEpidemiologyHealth Care Systems/ServicesMedicine/HealthPolicy/EthicsPublic HealthScience/Health and the LawScience/Health/Law
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Novel Plasma Synuclein Test Advances Parkinson’s Diagnosis

July 29, 2025
blank

Obesity’s Impact on Pancreatic Surgery Outcomes Compared

July 28, 2025

Virion Movement in Sialoglycan-Cleaving Respiratory Viruses

July 28, 2025

Bariatric Surgery’s Impact on Circulating S100A9

July 28, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    56 shares
    Share 22 Tweet 14
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    42 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    45 shares
    Share 18 Tweet 11
  • Engineered Cellular Communication Enhances CAR-T Therapy Effectiveness Against Glioblastoma

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cracking the Code of Cancer Drug Resistance

Peptidoglycan Links Prevent Lysis in Gram-Negative Bacteria

Novel Plasma Synuclein Test Advances Parkinson’s Diagnosis

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.